Unit Dose Packaging Market

Report Code PK 9105
Published in Aug, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Unit Dose Packaging Market by Form (Liquid, Solid, Powder, Gel), Material Type (Plastic, Glass, Paper, Aluminium), Product Type, End-use industry (Pharmaceuticals, Cosmetic & Personal Care, Nutraceuticals), and Region - Global Forecast to 2029

Overview

The global unit dose packaging market is valued at USD 29.1 billion in 2024 and is projected to reach USD 43.8 billion by 2029, growing at 8.5% CAGR from 2024 to 2029. The unit dose packaging market is expanding rapidly due to rising demand from key industries including pharmaceuticals, cosmetics and personal care, nutraceuticals, electronics, and food and beverage. This spike is being driven by rising healthcare spending in emerging economies and stricter environmental rules for packaging solutions. With the US playing a key part in this growth trajectory and a significant increase in both production and consumption of unit dosage packaging, North America is notably the fastest-growing market. The North American market is being pushed by the need for accurate and convenient medicine, rising healthcare expenditures, and the desire for effective drug management among ageing populations. The need for unit dose packaging is driven by key end-use industries such as pharmaceuticals, cosmetics and personal care, and nutraceuticals, which employ unit dose packaging for accurate dosing, user convenience, and safety enhancement.

Attractive Opportunities in the Unit Dose Packaging Market

North America

The unit dose packaging market in the North America region is driven by factors such as increasing need for precise and convenient medication and rising healthcare costs and the demand for effective medication management among aging populations.

The unit dose packaging market is poised for significant growth, driven by the increasing demand for blister packaging and consumer preference for convenience and portability.

Expansions, joint ventures mergers & acquisitions, partnerships & agreements, and collaborations are the key strategies adopted by the companies operating in this market.

The North America region accounted for a share of 33.5% in 2023 and is projected to register a CAGR of 8.5% during the forecast period, in terms of volume.

High initial investment for unit dose packaging presents significant challenges for the unit dose packaging industry is expected to be the primary factor restraining the unit dose packaging market.

Global Unit Dose Packaging Market Dynamics

DRIVER: Thriving Pharmaceutical Sector and surge in healthcare expenditure

The growing pharmaceutical sector and rising healthcare expenditure are key drivers of the unit dose packaging market. The expansion of the pharmaceutical industry increases the demand for precise, efficient, and safe medication delivery systems. Unit dose packaging, with its accurate, pre-measured doses, reduces dosing errors and enhances patient safety. For example, pre-filled syringes and single-use vials, which ensure exact medication amounts, minimizing waste and improving treatment outcomes. The rise in healthcare expenditure, driven by aging populations and chronic diseases, boosts investment in advanced packaging solutions. For instance, China's median age rose from about 20 years in 1970 to 37.5 years in 2020 and is expected to reach 60 by 2100. According to WHO's 2024 data, healthcare spending in 2021 was 9.89% of GDP in Brazil, 5.38% in China, and 3.38% in India. Factors such as population growth, government support, healthcare advancements, and emerging diseases contribute to this spending increase. Hospitals and healthcare providers adopt unit dose packaging to streamline medication administration, improve inventory management, and reduce contamination and medication errors. This is evident in the widespread use of blister packs for oral medications and single-dose containers for liquid drugs, supporting better adherence to treatments and enhancing healthcare efficiency.

RESTRAINT: The setup and maintenance of unit dose packaging machines

Setting up and maintaining unit dose packaging machines require substantial capital investment, presenting a significant barrier for small and medium-sized enterprises (SMEs) looking to enter the market. The high initial costs of these machines can hinder SMEs from competing effectively. The cost of pharmaceutical packaging machines varies widely based on type and complexity. For instance, a basic tablet blister sealing machine costs around USD 299.1 per unit, while advanced equipment like automatic two-head liquid vial filling machines is priced at approximately USD 2692.03 each. High-end machines, such as ALU blister packaging machines, can cost up to USD 23929.16 per piece. According to ResearchGate, the overall cost for manufacturer-based unit dose packaging systems is USD 91,272, whereas in-house packaging is calculated at USD 93,053, highlighting the significant financial burden of setting up in-house systems, including acquisition, labor, repackaging consumables, and maintenance costs. Ongoing expenses such as maintenance, regulatory compliance, and skilled labor further increase the financial burden on SMEs. These high costs can prevent SMEs from entering the market or expanding their operations, limiting their ability to compete and innovate within the unit dose packaging sector.

 

OPPORTUNITIES: Market expansion in nutraceuticals and cosmetics

The growth of the nutraceuticals and cosmetics markets is creating valuable opportunities for unit dose packaging, driven by changing consumer preferences and industry trends. In the nutraceutical sector, there is a rising demand for convenient and precise dosing options, which unit dose packaging addresses with pre-measured portions like single-dose sachets or vials. This simplifies daily supplementation and ensures accurate intake, such as single-dose sachets for vitamin C. In cosmetics, the trend towards personalized skincare and advanced delivery systems is supported by unit dose packaging, which offers precise dispensing of serums, lotions, and creams, preserving active ingredients and improving efficacy. Single-dose ampoules for facial serums, for example, provide freshness and exact dosing per application, meeting consumer preferences for hygiene and quality. Additionally, there is a growing emphasis on sustainability, driving the adoption of eco-friendly materials and designs in unit dose packaging for both nutraceuticals and cosmetics. Companies are exploring biodegradable materials and reducing packaging waste to align with environmental concerns and consumer expectations. The expansion of these markets presents robust opportunities for innovation in unit dose packaging, allowing brands to meet the demand for convenience, accuracy, and sustainability, and differentiate themselves in competitive markets.

CHALLENGES: High initial investment

The high initial investment required for unit dose packaging presents a significant challenge for companies, including new entrants and established players aiming to expand. This packaging demands specialized, costly machinery to ensure precise dosing, product integrity, and regulatory compliance, particularly in pharmaceuticals. Costs can reach hundreds of thousands or even millions of dollars, posing a financial burden, especially for small and medium-sized enterprises (SMEs). Securing funding for these expenses is often difficult, limiting SMEs' market competitiveness. SMEs also struggle with acquiring the technical expertise and resources needed to implement and maintain these technologies. Beyond equipment purchase, costs for installation, staff training, ongoing maintenance, and regulatory compliance strain financial resources and operational budgets, affecting profitability and long-term viability. While unit dose packaging offers precise dosing and product safety, the substantial upfront investment remains a major hurdle, impacting companies' growth prospects and competitive positioning.

Global Unit Dose Packaging Market Ecosystem Analysis

Liquid segment accounted for the largest form of unit dose packaging. As it is widely used in the pharmaceutical industry for injectable drugs and vaccines, liquid unit dose packaging is the market leader, with 42.5% of the overall market share in 2023. Pre-filled syringes and ampoules are widely used for giving insulin and vaccinations, providing precise dosing and cleanliness. In the nutraceutical industry, liquid dietary supplements and health shots, including energy boosters and liquid vitamins, are prominent due to their ease of use and quick absorption. With single-use vials of serums and face treatments offering precise application and minimising contamination, the cosmetics industry also benefits from liquid unit dose packaging. Liquid unit dose packaging extends the shelf life and safety of products by providing excellent defence against oxidation and contamination. This is especially important for the pharmaceutical and cosmetic industries, where sterility and product integrity are critical.

 

Glass segment accounted for the third largest material type of unit dose packaging

Glass, a hard and brittle substance formed by melting silica (sand) with additions like soda ash and limestone, cools to a clear or translucent, non-crystalline solid. It is preferred for unit dose packaging in a variety of sectors due to its superior barrier qualities and inert nature. Glass provides an impermeable barrier against gases, moisture, and odours, ensuring the integrity and stability of drugs, chemicals, and delicate products for extended durations. Recent advances in glass technology have resulted in developments such as laminated glass for increased safety, self-cleaning glass for simpler upkeep, and smart glass with adjustable transparency, energy-efficient (Low-E) glass for reduced heat transmission and improved illumination. These advancements are improving modern glass technology and broadening its applications. The COVID-19 pandemic highlighted the need of glass packaging, particularly for vaccine delivery, resulting in a significant surge in demand. Glass is commonly used to manufacture precision chemical reagents, medical devices such as prefilled syringes, and vials and ampoules for pharmaceutical unit dose packaging.

Ampoules & Vials segment accounted for the third largest product type of unit dose packaging

Ampoules and Vials are tiny, sealed containers for unit dose packaging. Vials are cylindrical with screw closures, whereas ampoules are sealed glass canisters that can be snapped open. Both are used for keeping and dispensing liquid medications, and are usually manufactured of glass or plastic to guarantee sterility and product integrity. Plastic ampoules are gaining demand because they have superior barrier qualities, greater dimensional stability, and a lower danger of breakage than glass. The growing global need for biologics, insulin, and vaccines is a significant driver of the vials and ampoules industry. Packaging is changing as a result of innovations like Blow-Fill-Seal (BFS) technology, which offers a flexible, affordable solution that satisfies strict sterility requirements and, due to its high automation, minimises the need for manual labour. Modern pharmaceutical packaging includes smart elements such as Near Field Communication (NFC), Radio Frequency Identification (RFID), and QR codes to provide extensive information about product quality, handling, storage, and delivery. Leading firms such as Schott AG and Gerresheimer AG are developing the industry with breakthroughs in glass composition and ready-to-fill technologies, respectively, to satisfy changing market demands and assure continuous growth in the ampoules and vials industry.Nutraceuticals end-use industry accounted for the third largest end-use industry of unit dose packaging.The nutraceutical sector uses a variety of unit dose packaging methods, such as sachets, stick packs, ampoules, capsules, and soft gel capsules, to ensure accurate supplement delivery. Unit dose packaging is critical in this industry because it ensures precise dosing, protects product integrity, and increases consumer compliance. Sachets and stick packs are adaptable packaging options for liquids, powders, capsules, tablets, and gummies. Paper and paperboard nutraceutical packaging innovations, such as improved branding and labelling, braille compliance features, and full regulatory information, are projected to propel the industry forward. Interactive packaging is an innovative design that mixes contemporary technology with traditional materials, including sensors that track product freshness and consumption in real time. Consumers can utilise mobile apps to access information about efficacy, safety, and environmental considerations. Amcor Plc and Constantia Flexibles are two key players that provide flexible packaging solutions for nutraceutical items, such as sachets, stick packs, pouches, and more.

Middle East Africa region holds the largest share of the Unit Dose Packaging Market.

According to the CIA World Factbook, all Middle Eastern and African countries are predicted to continue positive GDP growth rates, highlighting the region's relevance in the unit dose packaging industry. Government of Saudi Arabia pledged over USD 71 billion to achieving its Vision 2030 goals, including considerable investments in packaging. These investments are propelling the unit dosage packaging industry forward as manufacturers create innovative products. The growth of end-use industries like pharmaceuticals, cosmetics and personal care, and nutraceuticals is driving up demand for unit dose packaging. The market in the Middle East and Africa is mainly propelled by the healthcare industry's increasing demand for accurate and convenient drug delivery. The increase in chronic diseases, combined with the need for exact dosage and user-friendly drug formats, is driving healthcare practitioners and patients to favour unit dose packaging. Strict legal constraints pertaining to medication compliance and patient safety are also encouraging this packing solution. The region's developing pharmaceutical industry, combined with developments in packaging technology, is driving market expansion. Trends towards personalised treatment, as well as effective inventory management in hospitals and clinics, are boosting demand for unit dose packaging in the Middle East and Africa.

 
 

Recent Developments of Unit Dose Packaging Market industry

  • In April 2024, Pfizer Inc. launched a new single-dose vial of Idamycin PFS (idarubicin hydrochloride injection), 10 mg/10 mL (1 mg/mL). Its reinforced PVC bottom provides strong shatter resistance, enabling safe handling in delicate conditions. The clear and transparent design allows easy viewing, aiding confident and precise handling in healthcare environments. In January 2024, Amcor announces an expansion of its thermoforming production capacity to support healthcare customer growth in North America, including Wisconsin. This will meet clients’ growing pharmaceutical, consumer health, and medical needs. In February 2023, Corning Incorporated and Gerresheimer AG have joined forces to increase the global availability of the Velocity Vial technology platform. The goal is to improve access to efficient and cost-effective techniques for filling high-quality injectable pharmaceuticals.
  • In August 2022, West Pharmaceutical Services has invested strategically in Latch Medical Limited, a Dublin-based company specializing in innovative vaccination and biologics delivery technology via intradermal routes. This investment seeks to create and enhance products that improve the effectiveness and efficiency of healthcare delivery. In March 2023, Stevanato Group and Recipharm have teamed up to develop pre-fillable syringes, providing pharmaceutical companies with more packaging options. Stevanato Group will supply its Alba glass pre-fillable syringe and Recipharm's ISMTM technology for the Pre-Filled Syringe Inhaler (PFSITM).

Key Market Players

KEY PLAYERS IN THE Unit Dose Packaging Market INCLUDE

Want to explore hidden markets that can drive new revenue in Unit Dose Packaging Market?

Scope of the Report

Report Attribute Details
Market size available for years 2022–2029
Base year considered 2023
Forecast period 2024–2029
Forecast units Value (USD Million)
Segments Covered Form, Material Type, Product Type, End-Use Industry, and Region
Geographies covered North America, Asia Pacific, Europe, South America, and Middle East & Africa.
Companies covered Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klöckner Pentaplast (UK), among others. 25 manufacturers are covered in the unit dose packaging market.

 

Key Questions Addressed by the Report

What is unit dose packaging?
Unit dose packaging involves individually packaging products, such as pharmaceuticals, nutraceuticals, or cosmetics, in pre-measured amounts for single use. This method ensures accurate dosing, improves product safety, and simplifies administration by delivering ready-to-use portions in tamper-evident, often disposable, containers.
What are the forms of unit dose packaging?
Liquid, solid, powder, and gel.
What are the major end-use industries of unit dose packaging?
The major end-use industries of unit dose packaging include pharmaceuticals, cosmetic & personal care, and nutraceuticals industry.
What are the major drivers of the unit dose packaging market?
The major drivers of unit dose packaging are thriving pharmaceutical sector and surge in healthcare expenditure, rising demand for blister packaging, and consumer preference for convenience and portability driving demand for unit dose packaging.
What are the upcoming opportunities in the unit dose packaging market globally?
Increasing demand for primary pharmaceutical packaging, and market expansion in nutraceuticals and cosmetics are the upcoming opportunity in the unit dose packaging market globally.
What is the major restraint of the unit dose packaging market?
The setup and maintenance of unit dose packaging machines, and environmental concerns are the major restraints of the unit dose packaging market.
What are the major challenges of the unit dose packaging market?
Technological challenges in the unit dose packaging market, and high initial investment are the major challenges of the unit dose packaging market.
Who are the key players in the global unit dose packaging market?
The key players operating in the unit dose packaging market include Pfizer Inc. (US), Amcor Plc (Switzerland), Corning Incorporated (US), West Pharmaceutical Services (US), Stevanato Group (Italy), Gerresheimer AG (Germany), SCHOTT (Germany), Nipro (Japan), Constantia Flexibles (Austria), and Klöckner Pentaplast (UK).
What are the main drivers of growth in the unit dose packaging market in Europe?
The growth in Europe is driven by increasing healthcare spending, a rising aging population, and stringent regulations promoting patient safety and precise medication administration.
How is the demand for unit dose packaging being influenced by the pharmaceutical industry in North America?
In North America, the pharmaceutical industry's focus on reducing medication errors and improving patient compliance is significantly boosting the demand for unit dose packaging solutions.
How is the shift toward sustainability influencing unit dose packaging choices in Europe?
European regulations and consumer demand for sustainable options are driving innovations in eco-friendly materials, with a focus on recyclable and biodegradable unit dose packaging.
What technological advancements are influencing the unit dose packaging market?
Advancements such as automation in packaging lines, smart packaging with track-and-trace technologies, and the development of novel materials like biodegradable films are transforming the unit dose packaging market.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Unit Dose Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
22
RESEARCH METHODOLOGY
27
EXECUTIVE SUMMARY
38
PREMIUM INSIGHTS
42
MARKET OVERVIEW
45
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Thriving pharmaceutical sector and surge in healthcare expenditure
    - Rising demand for blister packaging
    - Consumer preference for convenience and portability
    RESTRAINTS
    - Substantial capital investment required for setup and maintenance of unit dose packaging machines
    - Environmental concerns
    OPPORTUNITIES
    - Increasing demand for primary pharmaceutical packaging
    - Market expansion in nutraceuticals and cosmetics
    CHALLENGES
    - Technological challenges
    - High initial investment
INDUSTRY TRENDS
51
  • 6.1 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 6.2 VALUE CHAIN ANALYSIS
  • 6.3 TRADE ANALYSIS
    EXPORT SCENARIO
    IMPORT SCENARIO
  • 6.4 IMPACT OF GEN AI ON UNIT DOSE PACKAGING
    INTEGRATING AI IN UNIT DOSE PACKAGING
    BEST PRACTICES TO LEVERAGE AI FOR UNIT DOSE PACKAGING MARKET
    USE CASES OF GENERATIVE AI IN UNIT DOSE PACKAGING MARKET
    - Future of generative AI in unit dose packaging market
  • 6.5 MACROECONOMIC INDICATORS
    GLOBAL GDP OUTLOOK
  • 6.6 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Blister packaging
    - Strip packaging
    - Blow-Fill-Seal
    COMPLEMENTARY TECHNOLOGIES
    - Smart packaging
    - Barrier and coating
  • 6.7 TARIFF AND REGULATORY LANDSCAPE
    TARIFF RELATED TO UNIT DOSE PACKAGING MARKET
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 6.8 CASE STUDY ANALYSIS
  • 6.9 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 6.10 KEY CONFERENCES & EVENTS IN 2024–2025
  • 6.11 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 6.12 ECOSYSTEM ANALYSIS
  • 6.13 PATENT ANALYSIS
    INTRODUCTION
    METHODOLOGY
  • 6.14 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE
    INVESTMENT AND FUNDING SCENARIO
UNIT DOSE PACKAGING MARKET, BY FORM
81
  • 7.1 INTRODUCTION
  • 7.2 LIQUID
  • 7.3 SOLID
  • 7.4 POWDER
  • 7.5 GEL
UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE
84
  • 8.1 INTRODUCTION
  • 8.2 PLASTIC
    POLYVINYL CHLORIDE
    POLYETHYLENE
    POLYPROPYLENE
    POLYETHYLENE TEREPHTHALATE
    OTHER PLASTIC FILMS
  • 8.3 GLASS
  • 8.4 PAPER & PAPERBOARD
  • 8.5 ALUMINUM
  • 8.6 OTHER MATERIAL TYPES
UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE
90
  • 9.1 INTRODUCTION
  • 9.2 BLISTER PACKS
    ENSURE DRUG DOSING ACCURACY AND INCREASED SAFETY
  • 9.3 SACHETS & STRIP PACKS
    MAINTAIN PRODUCT FRESHNESS AND QUALITY
  • 9.4 AMPOULES & VIALS
    USED FOR STORING AND DISPENSING LIQUID PHARMACEUTICALS
  • 9.5 OTHER PRODUCT TYPES
UNIT DOSE PACKAGING, BY END-USE INDUSTRY
94
  • 10.1 INTRODUCTION
  • 10.2 PHARMACEUTICALS
    INCREASED DEMAND FOR PREFILLED SYRINGES AND AUTO-INJECTORS
  • 10.3 COSMETICS & PERSONAL CARE
    EXTENDING SHELF LIFE OF BEAUTY PRODUCTS
  • 10.4 NUTRACEUTICALS
    ADMINISTRATION OF PRECISE DOSAGE AND CONSUMER COMPLIANCE
  • 10.5 OTHER END-USE INDUSTRIES
UNIT DOSE PACKAGING MARKET, BY REGION
98
  • 11.1 INTRODUCTION
  • 11.2 ASIA PACIFIC
    CHINA
    - Rising investments in biologics and biosimilar drug research to drive market
    INDIA
    - Large domestic consumption and export of generic drugs to drive market
    JAPAN
    - Surge in aging population to drive demand for medications
    SOUTH KOREA
    - Growth of cosmetic & personal care industries to drive market
    REST OF ASIA PACIFIC
  • 11.3 EUROPE
    GERMANY
    - Advanced healthcare infrastructure and emphasis on patient-centric care to drive market
    FRANCE
    - Surge in demand for generic drugs to drive market
    ITALY
    - Growing exports of pharmaceutical products to boost market
    UK
    - Innovations in drug manufacturing to drive market
    SPAIN
    - Growth of cosmetic & personal care industry to drive market
    REST OF EUROPE
  • 11.4 NORTH AMERICA
    US
    - Increasing demand for RFID integration and smart packaging to drive market
    CANADA
    - Rising demand for precise packaging to drive market
    MEXICO
    - Technological advancements and packaging innovations to boost market
  • 11.5 SOUTH AMERICA
    BRAZIL
    - Increased healthcare awareness and substantial investment to drive market
    ARGENTINA
    - Innovations in packaging to drive market
    REST OF SOUTH AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    GCC COUNTRIES
    - Saudi Arabia
    - UAE
    - Rest of GCC countries
    SOUTH AFRICA
    - Government initiatives upholding safety and efficacy standards to boost market
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
136
  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 PRODUCT/BRAND COMPARISON ANALYSIS
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Form footprint
    - Material type footprint
    - Product type footprint
    - End-use industry footprint
    - Region footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  • 12.9 COMPETITIVE SCENARIO AND TRENDS
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
158
  • 13.1 KEY PLAYERS
    PFIZER INC.
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    AMCOR PLC
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    CORNING INCORPORATED
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    WEST PHARMACEUTICAL SERVICES
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    STEVANATO GROUP
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    GERRESHEIMER AG
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    SCHOTT
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    NIPRO
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    CONSTANTIA FLEXIBLES
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
    KLOCKNER PENTAPLAST
    - Business overview
    - Products/Solutions/Services offered
    - Recent developments
    - MnM view
  • 13.2 OTHER PLAYERS
    SONIC PACKAGING INDUSTRIES INC.
    SHARP SERVICES, LLC
    TEKNI-PLEX, INC.
    THERMO-PAK CO. INC.
    APHENA PHARMA SOLUTIONS
    PACIFIC VIAL MANUFACTURING INC.
    HEALTH CARE LOGISTICS, INC.
    ULTRA SEAL CORPORATION
    SAFECORE HEALTH
    UNIT PACK
    JONES HEALTHCARE GROUP
    ROPACK INC.
    RX SYSTEMS, INC.
    JAMES ALEXANDER CORPORATION
    PHARMACY AUTOMATION SUPPLIES
ADJACENT & RELATED MARKETS
210
  • 14.1 INTRODUCTION
  • 14.2 LIMITATIONS
    PHARMACEUTICAL PACKAGING MARKET
    - Market definition
    - Pharmaceutical packaging market, by packaging type
    - Pharmaceutical packaging market, by raw material
    - Pharmaceutical packaging market, by drug delivery
    - Pharmaceutical packaging market, by type
    - Pharmaceutical packaging market, by region
    NUTRACEUTICAL PACKAGING MARKET
    - Market definition
    - Nutraceutical packaging market, by product form
    - Nutraceutical packaging market, by product type
    - Nutraceutical packaging market, by packaging type
    - Nutraceutical packaging market, by material
    - Nutraceutical packaging market, by ingredient
    - Nutraceutical packaging market, by region
APPENDIX
225
  • 15.1 DISCUSSION GUIDE
  • 15.2 CUSTOMIZATION OPTIONS
  • 15.3 RELATED REPORTS
  • 15.4 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 UNIT DOSE PACKAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 2 WORLD GDP GROWTH PROJECTION, 2019–2026 (USD BILLION)
  • TABLE 3 AVERAGE TARIFF BY COUNTRY
  • TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 7 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 8 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 PFIZER—ENHANCING MEDICATION COMPLIANCE IN ELDERLY PATIENTS
  • TABLE 10 WESTROCK COMPANY—IMPROVING OPERATIONAL EFFICIENCY IN UNIT DOSE PACKAGING PRODUCTION
  • TABLE 11 SHARP PACKAGING SOLUTIONS—INTEGRATING SMART TECHNOLOGY TO IMPROVE PATIENT ADHERENCE
  • TABLE 12 UNIT DOSE PACKAGING MARKET: KEY CONFERENCES & EVENTS, 2024–2025
  • TABLE 13 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR UNIT DOSE PACKAGING MARKET
  • TABLE 14 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES
  • TABLE 15 UNIT DOSE PACKAGING MARKET: ROLE OF PLAYERS IN ECOSYSTEM
  • TABLE 16 PATENTS IN UNIT DOSE PACKAGING MARKET, 2022–2023
  • TABLE 17 AVERAGE SELLING PRICE OF MATERIAL TYPE, BY KEY PLAYER, 2023 (USD/TON)
  • TABLE 18 UNIT DOSE PACKAGING MARKET, BY FORM, 2022–2029 (USD BILLION)
  • TABLE 19 UNIT DOSE PACKAGING MARKET, BY MATERIAL TYPE, 2022–2029 (USD BILLION)
  • TABLE 20 UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 21 UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 22 UNIT DOSE PACKAGING MARKET, BY REGION, 2022–2029 (USD BILLION)
  • TABLE 23 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 24 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 25 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 26 CHINA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 27 CHINA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 28 INDIA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 29 INDIA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 30 JAPAN: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 31 JAPAN: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 32 SOUTH KOREA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 33 SOUTH KOREA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 34 REST OF ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 35 REST OF ASIA PACIFIC: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 36 EUROPE: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 37 EUROPE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 38 EUROPE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 39 GERMANY: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 40 GERMANY: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 41 FRANCE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 42 FRANCE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 43 ITALY: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 44 ITALY: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 45 UK: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 46 UK: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 47 SPAIN: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 48 SPAIN: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 49 REST OF EUROPE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 50 REST OF EUROPE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 51 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 52 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 53 NORTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 54 US: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 55 US: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 56 CANADA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 57 CANADA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 58 MEXICO: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 59 MEXICO: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 60 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 61 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 62 SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 63 BRAZIL: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 64 BRAZIL: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 65 ARGENTINA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 66 ARGENTINA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 67 REST OF SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 68 REST OF SOUTH AMERICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 69 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY COUNTRY, 2022–2029 (USD BILLION)
  • TABLE 70 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 71 MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 72 GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 73 GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 74 SAUDI ARABIA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 75 SAUDI ARABIA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 76 UAE: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 77 UAE: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 78 REST OF GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 79 REST OF GCC COUNTRIES: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 80 SOUTH AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 81 SOUTH AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 82 REST OF MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY PRODUCT TYPE, 2022–2029 (USD BILLION)
  • TABLE 83 REST OF MIDDLE EAST & AFRICA: UNIT DOSE PACKAGING MARKET, BY END-USE INDUSTRY, 2022–2029 (USD BILLION)
  • TABLE 84 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN UNIT DOSAGE PACKAGING MARKET
  • TABLE 85 UNIT DOSE PACKAGING MARKET: DEGREE OF COMPETITION
  • TABLE 86 UNIT DOSE PACKAGING MARKET: FORM FOOTPRINT
  • TABLE 87 UNIT DOSE PACKAGING MARKET: MATERIAL TYPE FOOTPRINT
  • TABLE 88 UNIT DOSE PACKAGING MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 89 UNIT DOSE PACKAGING MARKET: END-USE INDUSTRY FOOTPRINT
  • TABLE 90 UNIT DOSE PACKAGING MARKET: REGION FOOTPRINT
  • TABLE 91 UNIT DOSE PACKAGING MARKET: KEY STARTUPS/SMES
  • TABLE 92 UNIT DOSE PACKAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 93 UNIT DOSE PACKAGING MARKET: PRODUCT LAUNCHES, JANUARY 2018–MAY 2024
  • TABLE 94 UNIT DOSE PACKAGING MARKET: DEALS, JANUARY 2018–MAY 2024
  • TABLE 95 UNIT DOSE PACKAGING MARKET: EXPANSIONS, JANUARY 2018–MAY 2024
  • TABLE 96 PFIZER INC.: COMPANY OVERVIEW
  • TABLE 97 PFIZER INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 98 PFIZER INC.: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 99 PFIZER INC.: DEALS, JANUARY 2018−MAY 2024
  • TABLE 100 AMCOR PLC: COMPANY OVERVIEW
  • TABLE 101 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 102 AMCOR PLC: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 103 AMCOR PLC: EXPANSION, JANUARY 2018−MAY 2024
  • TABLE 104 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 105 CORNING INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 106 CORNING INCORPORATED: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 107 CORNING INCORPORATED: DEALS, JANUARY 2018−MAY 2024
  • TABLE 108 WEST PHARMACEUTICAL SERVICES: COMPANY OVERVIEW
  • TABLE 109 WEST PHARMACEUTICAL SERVICES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 110 WEST PHARMACEUTICAL SERVICES: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 111 WEST PHARMACEUTICAL SERVICES: DEALS, JANUARY 2018−MAY 2024
  • TABLE 112 WEST PHARMACEUTICAL SERVICES: EXPANSION, JANUARY 2018−MAY 2024
  • TABLE 113 STEVANATO GROUP: COMPANY OVERVIEW
  • TABLE 114 STEVANATO GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 115 STEVANATO GROUP: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 116 STEVANATO GROUP: DEALS, JANUARY 2018−MAY 2024
  • TABLE 117 STEVANATO GROUP: EXPANSION, JANUARY 2018−MAY 2024
  • TABLE 118 GERRESHEIMER AG: COMPANY OVERVIEW
  • TABLE 119 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 120 GERRESHEIMER AG: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 121 GERRESHEIMER AG: DEALS, JANUARY 2018−MAY 2024
  • TABLE 122 GERRESHEIMER AG: EXPANSION, JANUARY 2018−MAY 2024
  • TABLE 123 SCHOTT: COMPANY OVERVIEW
  • TABLE 124 SCHOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 125 SCHOTT: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 126 SCHOTT: DEALS, JANUARY 2018−MAY 2024
  • TABLE 127 SCHOTT: EXPANSION, JANUARY 2018−MAY 2024
  • TABLE 128 NIPRO: COMPANY OVERVIEW
  • TABLE 129 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 130 NIPRO: PRODUCT LAUNCHES, JANUARY 2018−MAY 2024
  • TABLE 131 CONSTANTIA FLEXIBLES: COMPANY OVERVIEW
  • TABLE 132 CONSTANTIA FLEXIBLES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 133 CONSTANTIA FLEXIBLES: DEALS, JANUARY 2018−MAY 2024
  • TABLE 134 CONSTANTIA FLEXIBLES: EXPANSION, JANUARY 2018−MAY 2024
  • TABLE 135 KLOCKNER PENTAPLAST: COMPANY OVERVIEW
  • TABLE 136 KLOCKNER PENTAPLAST: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 137 KLOCKNER PENTAPLAST: EXPANSION, JANUARY 2018−MAY 2024
  • TABLE 138 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
  • TABLE 139 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
  • TABLE 140 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
  • TABLE 141 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
  • TABLE 142 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
  • TABLE 143 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
  • TABLE 144 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
  • TABLE 145 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
  • TABLE 146 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
  • TABLE 147 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
  • TABLE 148 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
  • TABLE 149 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
  • TABLE 150 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
  • TABLE 151 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
  • TABLE 152 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT FORM, 2019–2022 (USD MILLION)
  • TABLE 153 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT FORM, 2023–2028 (USD MILLION)
  • TABLE 154 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE, 2019–2022 (USD MILLION)
  • TABLE 155 NUTRACEUTICAL PACKAGING MARKET, BY PRODUCT TYPE, 2023–2028 (USD MILLION)
  • TABLE 156 NUTRACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2019–2022 (USD MILLION)
  • TABLE 157 NUTRACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
  • TABLE 158 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2019–2022 (USD MILLION)
  • TABLE 159 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2023–2028 (USD MILLION)
  • TABLE 160 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2019–2022 (KILOTON)
  • TABLE 161 NUTRACEUTICAL PACKAGING MARKET, BY MATERIAL, 2023–2028 (KILOTON)
  • TABLE 162 NUTRACEUTICAL PACKAGING MARKET, BY INGREDIENT, 2019–2022 (USD MILLION)
  • TABLE 163 NUTRACEUTICAL PACKAGING MARKET, BY INGREDIENT, 2023–2028 (USD MILLION)
  • TABLE 164 NUTRACEUTICAL PACKAGING MARKET, BY REGION, 2019–2022 (USD MILLION)
  • TABLE 165 NUTRACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
LIST OF FIGURES
 
  • FIGURE 1 UNIT DOSE PACKAGING: RESEARCH DESIGN
  • FIGURE 2 UNIT DOSE PACKAGING MARKET: TOP-DOWN APPROACH
  • FIGURE 3 UNIT DOSE PACKAGING MARKET: APPROACH 1
  • FIGURE 4 UNIT DOSE PACKAGING MARKET: APPROACH 2
  • FIGURE 5 UNIT DOSE PACKAGING MARKET: DATA TRIANGULATION
  • FIGURE 6 LIQUID FORM SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 7 PLASTIC SEGMENT TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 8 BLISTER PACKS TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 9 PHARMACEUTICALS TO BE LARGEST END-USE INDUSTRY DURING FORECAST PERIOD
  • FIGURE 10 NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 11 EMERGING ECONOMIES OFFER ATTRACTIVE OPPORTUNITIES IN UNIT DOSE PACKAGING MARKET
  • FIGURE 12 US DOMINATED UNIT DOSE PACKAGING MARKET IN 2023
  • FIGURE 13 BLISTER PACKS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 14 PHARMACEUTICALS TO LEAD UNIT DOSE PACKAGING MARKET DURING FORECAST PERIOD
  • FIGURE 15 CHINA PROJECTED TO GROW AT HIGHEST CAGR FROM 2024 TO 2029
  • FIGURE 16 UNIT DOSE PACKAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 VALUE FORECAST OF PHARMACEUTICAL EMPTY CAPSULES MARKET WORLDWIDE FROM 2021 TO 2032, BY RAW MATERIALS (USD MILLION)
  • FIGURE 18 UNIT DOSE PACKAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
  • FIGURE 19 UNIT DOSE PACKAGING: VALUE CHAIN ANALYSIS
  • FIGURE 20 EXPORT OF “3923 ARTICLES FOR THE CONVEYANCE OR PACKAGING OF GOODS, OF PLASTICS; STOPPERS, LIDS, CAPS, AND OTHER CLOSURES, OF PLASTICS,” BY KEY COUNTRY, 2019–2023
  • FIGURE 21 IMPORT OF 280610 “3923 ARTICLES FOR THE CONVEYANCE OR PACKAGING OF GOODS, OF PLASTICS; STOPPERS, LIDS, CAPS, AND OTHER CLOSURES, OF PLASTICS,” BY KEY COUNTRY, 2019–2023
  • FIGURE 22 EMERGING TRENDS AND ADVANCEMENTS IN TECHNOLOGY TO CHANGE FUTURE REVENUE MIX OF SUPPLIERS
  • FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 END-USE INDUSTRIES
  • FIGURE 24 KEY BUYING CRITERIA FOR TOP 3 END-USE INDUSTRIES
  • FIGURE 25 UNIT DOSE PACKAGING MARKET: ECOSYSTEM
  • FIGURE 26 NUMBER OF PATENTS GRANTED FOR UNIT DOSE PACKAGING, 2013–2023
  • FIGURE 27 REGIONAL ANALYSIS OF PATENTS GRANTED FOR UNIT DOSE PACKAGING, 2013–2023
  • FIGURE 28 AVERAGE SELLING PRICE OF PHARMACEUTICAL PACKAGING, BY REGION (USD/KG)
  • FIGURE 29 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL TYPE (USD/KG)
  • FIGURE 30 INVESTOR DEALS AND FUNDING IN UNIT DOSE PACKAGING SOARED IN 2023
  • FIGURE 31 LIQUID SEGMENT TO REGISTER HIGHEST GROWTH THROUGH 2029
  • FIGURE 32 PLASTICS SEGMENT TO REGISTER HIGHEST CAGR THROUGH 2029
  • FIGURE 33 BLISTER PACKS SEGMENT TO RECORD HIGHEST GROWTH THROUGH 2029
  • FIGURE 34 PHARMACEUTICALS INDUSTRY TO BE LARGEST CONSUMER OF UNIT DOSE PACKAGING
  • FIGURE 35 UNIT DOSE PACKAGING MARKET GROWTH RATE, BY COUNTRY, 2024–2029
  • FIGURE 36 ASIA PACIFIC: UNIT DOSE PACKAGING MARKET SNAPSHOT
  • FIGURE 37 EUROPE: UNIT DOSE PACKAGING MARKET SNAPSHOT
  • FIGURE 38 NORTH AMERICA: UNIT DOSE PACKAGING MARKET SNAPSHOT
  • FIGURE 39 REVENUE ANALYSIS OF KEY COMPANIES IN LAST FIVE YEARS
  • FIGURE 40 UNIT DOSE PACKAGING MARKET: MARKET SHARE ANALYSIS
  • FIGURE 41 COMPANY VALUATION (USD BILLION)
  • FIGURE 42 FINANCIAL MATRIX: EV/EBITDA RATIO
  • FIGURE 43 PRODUCT COMPARISON
  • FIGURE 44 UNIT DOSE PACKAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 45 UNIT DOSE PACKAGING MARKET: COMPANY FOOTPRINT
  • FIGURE 46 UNIT DOSE PACKAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 47 PFIZER INC.: COMPANY SNAPSHOT
  • FIGURE 48 AMCOR PLC: COMPANY SNAPSHOT
  • FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 50 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT
  • FIGURE 51 STEVANATO GROUP: COMPANY SNAPSHOT
  • FIGURE 52 GERRESHEIMER AG: COMPANY SNAPSHOT
  • FIGURE 53 NIPRO: COMPANY SNAPSHOT

The study involved four major activities for estimating the current size of the global unit dose packaging market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of unit dose packaging through primary research. Both the top-down and bottom-up approaches were employed to estimate the overall size of the unit dose packaging market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

In the secondary research process, various secondary sources such as Hoovers, Factiva, Bloomberg BusinessWeek, and Dun & Bradstreet were referred to, to identify and collect information for this study on the unit dose packaging market. These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; regulatory bodies, trade directories, and databases.

Primary Research

The unit dose packaging market comprises several stakeholders in the supply chain, which include raw material suppliers, processors, end-product manufacturers, buyers, and regulatory organizations. Various primary sources from the supply and demand sides of the markets have been interviewed to obtain qualitative and quantitative information. The primary participants from the demand side include key opinion leaders, executives, vice presidents, and CEOs of companies in the Unit dose packaging market. Primary sources from the supply side include associations and institutions involved in the unit dose packaging industry, key opinion leaders, and processing players.

Following is the breakdown of primary respondents

Unit Dose Packaging Market Size, and Share

Notes: Other designations include product, sales, and marketing managers.

Tiers of the companies are classified based on their annual revenues as of 2022: Tier 1 = >USD 5 Billion, Tier 2 = USD 1 Billion to USD 5 Billion, and Tier 3= <USD 1 Billion.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both the top-down and bottom-up approaches were used to estimate and validate the size of the global unit dose packaging market. These approaches were also used extensively to estimate the size of various segments of the market. The research methodology used to estimate the market size included the following details:

  • The key players in the industry were identified through extensive secondary research.
  • The supply chain of the industry and market size, in terms of value, were determined through primary and secondary research.
  • All percentage share splits and breakdowns were determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study were accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.
  • The research includes the study of reports, reviews, and newsletters of key industry players, along with extensive interviews with key officials, such as directors and marketing executives.

Unit Dose Packaging Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Unit Dose Packaging Market Size, and Share

Data Triangulation

After arriving at the overall market size from the estimation process explained above, the total market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all the segments and sub-segments of the unit dose packaging market. The data was triangulated by studying various factors and trends from both the demand- and supply-side.

In addition, the market size was validated by using both the top-down and bottom-up approaches. Then, it was verified through primary interviews. Hence, for every data segment, there are three sources—top-down approach, bottom-up approach, and expert interviews. The data were assumed to be correct when the values arrived at from the three sources matched.

Market Definition

The unit dose packaging market focuses on providing single-serving or single-dose packaging solutions that ensure precise dosage, enhance convenience, improve hygiene, and protect product integrity. In the pharmaceutical industry, unit dose packaging ensures accurate dosing, reduces contamination risks, and boosts patient compliance, commonly used for syrups, oral suspensions, and injectables. In the cosmetics sector, it offers convenience and hygiene for serums, lotions, and treatments with easy-to-apply, portable single-use portions. The nutraceutical industry benefits from unit dose packaging by delivering precise, easily consumable doses of liquid supplements and vitamins, ensuring consistent intake and maintaining product integrity. This packaging method enhances accuracy, convenience, and safety, making it a valuable solution across these diverse applications.

Key Stakeholders

  • Unit dose packaging producing companies
  • Raw material suppliers and producers
  • Regulatory bodies
  • End-use industries of unit dose packaging
  • Associations and industrial bodies
  • Local governments
  • Market research and consulting firms

Report Objectives

  • To define, analyze, and project the size of the unit dose packaging market in terms of value based on form, material type, product type, end-use industry, and region.
  • To project the size of the market and its segments with respect to the five main regions, namely, North America, Europe, Asia Pacific, Middle East & Africa, and South America
  • To provide detailed information about the key factors, such as drivers, restraints, opportunities, and challenges, influencing the growth of the market
  • To analyze the opportunities in the market for stakeholders and provide a detailed competitive landscape of the market leaders.
  • To analyze the competitive developments, such as new product launches, expansions, and acquisitions, in the unit dose packaging market
  • To strategically profile the key players operating in the market and comprehensively analyze their market shares and core competencies.

Available Customizations

Along with the given market data, MarketsandMarkets offers customizations as per the specific needs of the companies. The following customization options are available for the report:

Product Analysis:

  • Product Matrix which gives a detailed comparison of the product portfolio of each company

Regional Analysis:

  • Further breakdown of the Rest of Asia Pacific market
  • Further breakdown of Rest of Europe market

Company Information:

  • Detailed analysis and profiling of additional market players (up to 5)

Previous Versions of this Report

"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.

By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Unit Dose Packaging Market

+1-888600-6441

Corporate Office Hours

+1-888600-6441

US/Can Toll Free

+44-800-368-9399

UK Office Hours

©2024 Marketsandmarkets Research Private Ltd. All Rights Reserved.

DMCA.com Protection Status